Particularly, the loss of neuronal PP2 A/Bα holoenzymes correlates with the down-regulation of PP2 A methylation and severity of phosphorylated tau pathology in AD-affected brain regions (Sontag et al. 2014). The gene discussed is MAPT; the disease is Alzheimer disease.